Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96G97: Variant p.Ala212Pro

Seipin
Gene: BSCL2
Feedback?
Variant information Variant position: help 212 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Proline (P) at position 212 (A212P, p.Ala212Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CGL2; increases localization to nuclear envelope; no effect on its interaction with LDAF1; no rescue of aberrant lipid droplet formation in BSCL2-knockdown cells. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 212 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 398 The length of the canonical sequence.
Location on the sequence: help YVPTTGAIIEIHSKRIQLYG A YLRIHAHFTGLRYLLYNFPM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         YVPTTGAIIEIHSKRIQLYGAYLRIHAHFTGLRYLLYNFPM

Mouse                         YVPTTGAIIEIHSKRIQMYGAYLRIHAHFTGLRYLLYNFPM

Rat                           YVPTTGAIIEVHSKRVQMYGAYLRIHAHFTGLRYLLYNFPM

Bovine                        YVPTTGAIIEIHSKRIQMYGAYLRIHAHFTGLRYLLYNFPM

Drosophila                    QHPITDVYVEIQSQKIQFYTVTLHIVADFTGLRYIMFNWPV
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 398 Seipin
Topological domain 48 – 242 Lumenal



Literature citations
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.
Magre J.; Delepine M.; Khallouf E.; Gedde-Dahl T. Jr.; Van Maldergem L.; Sobel E.; Papp J.; Meier M.; Megarbane A.; Bachy A.; Verloes A.; d'Abronzo F.H.; Seemanova E.; Assan R.; Baudic N.; Bourut C.; Czernichow P.; Huet F.; Grigorescu F.; de Kerdanet M.; Lacombe D.; Labrune P.; Lanza M.; Loret H.; Matsuda F.; Navarro J.; Nivelon-Chevalier A.; Polak M.; Robert J.J.; Tric P.; Tubiana-Rufi N.; Vigouroux C.; Weissenbach J.; Savasta S.; Maassen J.A.; Trygstad O.; Bogalho P.; Freitas P.; Medina J.L.; Bonnicci F.; Joffe B.I.; Loyson G.; Panz V.R.; Raal F.J.; O'Rahilly S.; Stephenson T.; Kahn C.R.; Lathrop M.; Capeau J.;
Nat. Genet. 28:365-370(2001)
Cited for: TISSUE SPECIFICITY; VARIANT CGL2 PRO-212; The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation.
Payne V.A.; Grimsey N.; Tuthill A.; Virtue S.; Gray S.L.; Dalla Nora E.; Semple R.K.; O'Rahilly S.; Rochford J.J.;
Diabetes 57:2055-2060(2008)
Cited for: SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANT PRO-212; Seipin regulates ER-lipid droplet contacts and cargo delivery.
Salo V.T.; Belevich I.; Li S.; Karhinen L.; Vihinen H.; Vigouroux C.; Magre J.; Thiele C.; Hoelttae-Vuori M.; Jokitalo E.; Ikonen E.;
EMBO J. 35:2699-2716(2016)
Cited for: CHARACTERIZATION OF VARIANT CGL2 PRO-212; FUNCTION; SUBCELLULAR LOCATION; Promethin Is a Conserved Seipin Partner Protein.
Castro I.G.; Eisenberg-Bord M.; Persiani E.; Rochford J.J.; Schuldiner M.; Bohnert M.;
Cells 8:0-0(2019)
Cited for: CHARACTERIZATION OF VARIANT CGL2 PRO-212; INTERACTION WITH LDAF1; INDUCTION; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.